CN107259003A - A kind of lycium ruthenicum Moringa ginseng health protection tea and its application - Google Patents
A kind of lycium ruthenicum Moringa ginseng health protection tea and its application Download PDFInfo
- Publication number
- CN107259003A CN107259003A CN201710334173.0A CN201710334173A CN107259003A CN 107259003 A CN107259003 A CN 107259003A CN 201710334173 A CN201710334173 A CN 201710334173A CN 107259003 A CN107259003 A CN 107259003A
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- moringa
- ginseng
- lycium ruthenicum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 39
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 39
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 39
- 235000011347 Moringa oleifera Nutrition 0.000 title claims abstract description 36
- 241000169546 Lycium ruthenicum Species 0.000 title claims abstract description 35
- 230000036541 health Effects 0.000 title claims abstract description 21
- 244000179886 Moringa oleifera Species 0.000 title claims abstract 6
- 244000269722 Thea sinensis Species 0.000 title claims abstract 5
- 244000131316 Panax pseudoginseng Species 0.000 title 1
- 241000208340 Araliaceae Species 0.000 claims abstract description 39
- 239000000203 mixture Substances 0.000 claims abstract description 19
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 16
- 241000234435 Lilium Species 0.000 claims abstract description 15
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 15
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 15
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 15
- 230000007958 sleep Effects 0.000 claims abstract description 14
- 238000011282 treatment Methods 0.000 claims description 21
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 239000010836 blood and blood product Substances 0.000 claims description 2
- 229940125691 blood product Drugs 0.000 claims description 2
- 201000001421 hyperglycemia Diseases 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000002265 prevention Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000001603 reducing effect Effects 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 208000001953 Hypotension Diseases 0.000 abstract description 2
- 208000021822 hypotensive Diseases 0.000 abstract description 2
- 230000001077 hypotensive effect Effects 0.000 abstract description 2
- 210000000056 organ Anatomy 0.000 abstract description 2
- 150000003254 radicals Chemical class 0.000 abstract description 2
- 241000220215 Moringa Species 0.000 description 31
- 241001122767 Theaceae Species 0.000 description 24
- 230000000694 effects Effects 0.000 description 18
- 210000004556 brain Anatomy 0.000 description 11
- 238000011443 conventional therapy Methods 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000009467 reduction Effects 0.000 description 4
- -1 blood pressure Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000002710 Ilex cornuta Nutrition 0.000 description 2
- 241001310146 Ilex cornuta Species 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241001247821 Ziziphus Species 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000036995 brain health Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003181 encephalopathic effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of lycium ruthenicum Moringa ginseng health protection tea and its application, in mass ratio, including 25 35 parts of lycium ruthenicum, 15 25 parts of leaf of Moringa, 15 25 parts of ginseng, 5 15 parts of gingko, 5 15 parts of lily, 5 15 parts of lotus seeds.The present composition can be with（1）Improve body immunity, hypotensive, hypoglycemic, reducing blood lipid.（2）Fatigue-relieving, promotion sleep.（3）Remove free radical, anti-aging.By the complex function of the raw materials such as lycium ruthenicum, leaf of Moringa, ginseng, gingko, lily, lotus seeds, drunk with tea generation, nurse one's health the function of each organ of human body, reach the purpose of " putting prevention first and combining prevention with control ".
Description
Technical field
The present invention relates to a kind of field of health-care tea, available for blood glucose, blood pressure, blood fat and the sleep for preparing three high crowds for the treatment of
The product of obstacle.
Background technology
China is drinks tea big country, and tea culture is of long standing and well established, and the health beverages species of in the market is various, effect be also the good and the bad not
Together.With China's expanding economy, the rich and powerful and improvement of people's living standards of country, great change, " three occur for dietary structure
It is high " crowd is in the situation risen year by year, and body and mind inferior health is caused a significant threat to quality of life, causes national and society wide
General concern, the survey showed that by one of WHO announcements, and the population of whole world true health only accounts for 5%, and inferior health population is accounted for
75%, remaining is morbid state.
Wild lycium ruthenicum is one kind that category is Solanaceae Lycium, sweet, mild-natured；Berry is spherical, thin skin, is purple black after maturation
Color.Include K, Na, Fe, Ca, Mg in black fruit fructus lycii relatively to enrich, especially K content will be significantly larger than the content of sodium, be a kind of allusion quotation
The fruit of the hyperkalemia hyponatremia of type, and Fe, Se, Zn content are similar to pork liver, higher than all fruit and vegetable juices, its medicinal health value is much
Higher than red matrimony vine, it is described as " soft gold ".It, which includes abundant anthocyanin element and OPC, has preventing hypertension, the protection heart
Blood vessel, antitumor, protection eyesight and the effect such as promote longevity；The flavone compound such as the rutin included and Quercetin has anti-ageing
Effect of old and reducing blood lipid, the preventing and treating available for atherosclerosis.
Moringa Moringaceae, Moringa, are a kind of perennial tropical plants being worth with unique economic, are distributed mainly on
More than 30 tropical, semi-tropical countries and regions such as India, China, Japan, Egypt, U.S..Rich in VA、VB、VC、VEAnd Ca, K,
The mineral nutrient elements such as Fe, wherein Ca and protein content are respectively 4 times and 2 times of milk, and K is 3 times of banana, and Fe is spinach
3 times, VCIt is 7 times of citrus, VAIt is 4 times of carrot, is described as " tree of miracle ", complete stool is all available, nutriment species
It is many.Leaf juice has effects that stabilizing blood pressure and treatment are melancholy；The glucose level of controllable diabetes patient；Rubbed with leaf and tender shoots
Temple treatment headache；The mud application being made of fresh leaf can treat the diseases such as glandular hyperplasia, ulcer and skin infection；Edible blade
Milk volume can be increased, and have functions that to treat anemia.
Ginseng is dry for the dry root of Araliaceae thing ginseng, is Relict Plant, is also precious Chinese medicine, in China's medicinal history
It is long.Ginseng can adjust central nervous system, promote utilization of the brain to energy matter, and ginseng can increase myocardial contractive power, subtract
Slow heart rate, increase cardiac output and coronary blood flow, can be resisted myocardial ischemia and arrhythmia cordis, and ginsenoside and people are contained in ginseng
Gracilis polysaccharide, especially ginsenoside Rb2 have obvious hypoglycemic effect, strengthen the immunologic function of body, improve to destructive stimulus
Defensive ability/resistance ability, the stress ability and adaptability of body, antitumor action, antioxidation can be strengthened.
The raw materials such as dry lycium ruthenicum fruit, dried hawthorn, jujube nucleus, rock sugar, persimmon leaves, chrysanthemum are made a kind of by CN105494795A
Lycium ruthenicum health protection tea, only with the effect for promoting sleep；CN 104757216A ginseng fibrous roots concentrate, jujube concentrate, Radix Angelicae Sinensis are dense
The raw materials such as contracting liquid, oriental wormwood concentrate make ginseng tea, the only effect with fatigue-relieving, and both are without the compositions such as leaf of Moringa, regulation
The effect of body immunity is weaker；
Patent CN 105558178A, CN 102524470A describe a kind of Moringa leaf tea and the processing method of gingko, but
Composition is single, the effect for not possessing compound regulation body immunity；
In summary, in prior art, the single health beverages of composition, the effect without combined cooker body immunity
Really.Composite health care drink, the composition such as no leaf of Moringa, the effect for nursing one's health body immunity is weaker.
The content of the invention
The technical problem of solution：The present invention provides a kind of health protection tea, by drinking the health protection tea, improves body immunity,
Reduce by three excessive risks；" three high " crowd drinks health protection tea, coordinates drug therapy, optimizes body indices, improves the quality of living.
Technical scheme：A kind of health protection tea composition, it is characterised in that in mass ratio, including 25-35 parts of lycium ruthenicum, leaf of Moringa
15-25 parts, 15-25 parts of ginseng, 5-15 parts of gingko, 5-15 parts of lily, 5-15 parts of lotus seeds.
It is preferred that, the component of above-mentioned health protection tea in mass ratio is：30 parts of lycium ruthenicum, 20 parts of leaf of Moringa, 20 parts of ginseng, gingko
10 parts, 10 parts of lily, 10 parts of lotus seeds.
Application of the above-mentioned composition in treatment hypertension product is prepared.
Application of the above-mentioned composition in treatment hyperglycaemia product is prepared.
Application of the above-mentioned composition in treatment high fat of blood product is prepared.
Above-mentioned composition is preparing the application in improving sleep product.
Beneficial effect：The present composition can (1) raising body immunity, hypotensive, hypoglycemic, reducing blood lipid.(2) delay
Solution fatigue, promotion sleep.(3) free radical, anti-aging are removed.Pass through lycium ruthenicum, leaf of Moringa, ginseng, gingko, lily, lotus seeds etc.
The complex function of raw material, is drunk with tea generation, nurses one's health the function of each organ of human body, reach the purpose of " putting prevention first and combining prevention with control ".
Embodiment
Embodiment 1
Lycium ruthenicum tea-drinking, Moringa ginseng mixing tea-drinking and lycium ruthenicum Moringa ginseng tea are drunk case history in three high crowd's clinics and seen
Examine：
By mass parts
A is formulated：70 parts of lycium ruthenicum, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds；
B is formulated：35 parts of leaf of Moringa, 35 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds；
C is formulated：30 parts of lycium ruthenicum, 20 parts of leaf of Moringa, 20 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds.
Preparation method
After each composition in formula is crushed, dispensing, dried 20~30 mesh sieves and obtains product, when using in proportion after mixing
Brewed with boiling water and produce tea-drinking.
1st, three high crowd's conventional therapies are observed and A formulas tea-drinking is drunk in packet, B is formulated tea-drinking and C matches somebody with somebody in conventional therapy
The clinical application effect contrast of square tea-drinking.
From in March, 2013 in September, 2016 part to drinking, A formulas tea-drinking, B are formulated tea-drinking to applicant and C is formulated tea-drinking
The influence for reducing diabetes B blood glucose, blood pressure, blood lipid metabolism and Advanced glycation endproducts (AGEs) carries out observational study.
2nd, selection is in hospital and random be grouped into of the diabetes B patient 90 by WHO standard of outpatient service drinks A formula tea
Drink, B formula tea-drinkings and C are formulated each 30 of tea-drinking and do not take tea conventional therapy 30, alternative condition such as following table：
The diabetic's clinical case overview of table 1
Observation index：Empty stomach 0h and 100g steamed bun 2h-plasma glucose and blood fat, and using same sphygmomanometer, when same
Between, same person measurement blood pressure.
The conventional therapy of table 2 and conventional therapy+A formula tea-drinkings three high crowd observation contrast record sheet
Conventional therapy+the B of table 3 is formulated tea-drinking and is formulated tea-drinking to three high crowd's observation contrast record sheets with conventional therapy+C
4th, experimental result
4.1 effect：Conventional therapy coordinates again drinks A formulas tea-drinking, B formulas tea-drinking, C formula tea-drinkings and conventional therapy phase
Than the blood glucose of, 3 observation groups, blood pressure, blood fat, AGEs compared with control group, there is improvement, specifically refer to table 4
4.2 adverse reaction：There is the adverse reaction of 3 slight abdominal distension in experimental group A formula tea-drinkings, are relieved after 2 hours,
Other reasonses are excluded to cause；5 0h-PG and 2h-PG is raised, and analysis reason is that sugar is higher in lycium ruthenicum and individual physique draws
Rise, use instead C be formulated tea-drinking after three months 5 blood glucose rise turn to reduction and recover normal, other experimental groups and control group are normal
Carry out.
The experimental group of table 4 and control group statistical result
5th, conclusion：
Lycium ruthenicum Moringa ginseng tea main component is lycium ruthenicum, leaf of Moringa, ginseng, gingko, lily and lotus seeds etc., wherein black Chinese holly
Qi, leaf of Moringa and ginseng are key component, and remaining is helper component.
Matched somebody with somebody by being grouped in March, 2013 in September, 2016 to drink A and be formulated tea-drinking, B on the basis of conventional therapy diabetes
In the contrast experiment of square tea-drinking and C formula tea-drinking, it is found that A formula tea-drinking groups hypoglycemic, decompression, lipid-lowering effect are better than control group, it is low
In other observation groups, there are 5 blood glucose to raise, be, because of lycium ruthenicum sugar and individual physique reason, to use instead and drink C formulas, it is extensive
It is multiple normal；B formula tea-drinking groups hypoglycemic, decompression, lipid-loweringing and reduction AGEs effects are substantially better than control group；C formula tea-drinking groups hypoglycemic,
Decompression, lipid-loweringing and reduction AGEs effects are substantially better than other test groups, illustrate that C formula tea-drinkings have compound action, in hypoglycemic, drop
Pressure, the effect of lipid-loweringing are substantially better than the tea-drinking and control group that A formula tea-drinkings group, B are formulated tea-drinking group.
In summary, the various ingredients of lycium ruthenicum Moringa ginseng tea are mutually cooperateed with, in the high crowd of clinical treatment three, to control
With stabilizing blood sugar, blood pressure, blood fat, reduction AGEs in terms of have good auxiliary therapeutic action, hence it is evident that lifting minimal invasive treatment's matter
Amount.
Embodiment 2
Lycium ruthenicum tea-drinking, Moringa ginseng mixing tea-drinking and lycium ruthenicum Moringa ginseng tea improve the observation of sleep quality clinical case history：
By mass parts
A is formulated：30 parts of lycium ruthenicum, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds；
B is formulated：20 parts of leaf of Moringa, 20 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds；
C is formulated：30 parts of lycium ruthenicum, 20 parts of leaf of Moringa, 20 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds.
Preparation method
After each composition in formula is crushed, dispensing, dried 20~30 mesh sieves and obtains product, when using in proportion after mixing
Brewed with boiling water and produce tea-drinking.
1st, purpose is observed：Observe brain electric therapeutic instrument for rehabilitation and brain electric therapeutic instrument for rehabilitation+lycium ruthenicum tea-drinking, the electric rehabilitation of brain
Instrument+Moringa ginseng mixing tea-drinking and brain electric therapeutic instrument for rehabilitation+lycium ruthenicum Moringa ginseng tea improve the clinical effectiveness of sleep quality.
2nd, method：In Fuyang, diabetes Hospital choice is in hospital insomniac 100, is randomly divided into 3 observation combinations each 25
Example and control group 25, control group are treated using encephalopathic therapeutic instrument for rehabilitation, and 3 groups of observation groups are on the basis of control group plus use black Chinese holly
Qi, Moringa ginseng mixing tea-drinking and lycium ruthenicum Moringa ginseng tea, the 2 Monday courses for the treatment of, observe four course for the treatment of result observation treatments respectively
The efficient statistical analysis of group.
2.1 control group：Brain electric therapeutic instrument for rehabilitation, once a day, the 2 Monday courses for the treatment of treat 4 courses for the treatment of, middle uninterrupted.
2.2 observation group：On the basis of control group, adhere to drinking A formulas tea-drinking, B formulas tea-drinking, C formula tea-drinkings, 2 daily
The Monday course for the treatment of, treats four courses for the treatment of, middle uninterrupted.
3rd, conclusion is judged
3.1 curative effect determinate standard：
Cure：Can continuously it sleep more than 6 hours and the middle person that do not wake up.
Significantly：Can prolonged sleep more than 6 hours and a middle awake person.
Effectively：The length of one's sleep not awake person in the middle of 4~6 hours.
4th, experimental record：
Progress clinical test on March 15th, 2013 was grouped and tested in batches on the 25th to September in 2016, and gathered data is as follows
Table
Table 5, experimental group and control group statistical result
Take A formulas tea-drinking, B formula tea-drinkings and C and be formulated tea-drinking to sleep improvement conclusive table
Brain health instrument：Hundred strange Brain health instruments difficult to understand, YY-I types
5th, conclusion
Lycium ruthenicum Moringa ginseng tea main component is lycium ruthenicum, leaf of Moringa, ginseng, gingko, lily and lotus seeds etc., wherein black
Matrimony vine, leaf of Moringa and ginseng are key component, and remaining is helper component.
Observation herein is taken lycium ruthenicum tea-drinking, Moringa ginseng mixing tea-drinking and lycium ruthenicum Moringa ginseng tea and had a sleepless night in clinical treatment
Contrast experiment.
By March in 2013, the statistical result of 15 days to 2016 on Septembers, 25, clinical treatments showed, simple to use brain Kang Yi
More than the 6 hours middle persons that do not wake up of therapeutic equipment group account for 52%；The person that waken up in the middle of more than 6 hours accounts for 24%；In the middle of 4~6 hours not
Awake person accounts for 24%；It is obviously improved patient sleeps' mass.
More than the 6 hours middle persons that do not wake up of brain Kang Yi+A formula tea-drinkings group account for 60%；The person that waken up in the middle of more than 6 hours accounts for
24%；The person that do not waken up in the middle of 4~6 hours accounts for 16%；Compared with control group, with the effect for being obviously improved sleep quality.
More than the 6 hours middle persons that do not wake up of brain Kang Yi+B formula tea-drinkings group account for 56%；Waken up in the middle of more than 6 hours a short time
Sleep person accounts for 24%；The person that do not waken up in the middle of 4~6 hours accounts for 20%；Effect is better than control group, not as good as brain Kang Yi+lycium ruthenicum tea-drinking group.
More than the 6 hours middle persons that do not wake up of brain Kang Yi+C formula tea-drinkings group account for 72%；Waken up in the middle of more than 6 hours a short time
Sleep person accounts for 20%；The person that do not waken up in the middle of 4~6 hours accounts for 8%, the best results in all experimental groups.
In summary, the various ingredients of lycium ruthenicum Moringa ginseng tea are mutually cooperateed with, right during clinical treatment insomnia crowd
Promote that there is good auxiliary therapeutic action in terms of sleep.
Claims (6)
1. a kind of health protection tea composition, it is characterised in that in mass ratio, including 25-35 parts of lycium ruthenicum, 15-25 parts of leaf of Moringa, people
15-25 parts of ginseng, 5-15 parts of gingko, 5-15 parts of lily, 5-15 parts of lotus seeds.
2. health protection tea composition according to claim 1, it is characterised in that 30 parts of the lycium ruthenicum, 20 parts of leaf of Moringa, people
20 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds.
3. application of the composition described in claim 1 or 2 in treatment hypertension product is prepared.
4. application of the composition described in claim 1 or 2 in treatment hyperglycaemia product is prepared.
5. application of the composition described in claim 1 or 2 in treatment high fat of blood product is prepared.
6. composition described in claim 1 or 2 is preparing the application in improving sleep product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710334173.0A CN107259003B (en) | 2017-05-12 | 2017-05-12 | A kind of lycium ruthenicum Moringa ginseng health protection tea and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710334173.0A CN107259003B (en) | 2017-05-12 | 2017-05-12 | A kind of lycium ruthenicum Moringa ginseng health protection tea and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107259003A true CN107259003A (en) | 2017-10-20 |
| CN107259003B CN107259003B (en) | 2018-04-20 |
Family
ID=60073923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710334173.0A Expired - Fee Related CN107259003B (en) | 2017-05-12 | 2017-05-12 | A kind of lycium ruthenicum Moringa ginseng health protection tea and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107259003B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107691720A (en) * | 2017-11-08 | 2018-02-16 | 王中菊 | A kind of Moringa nurses one's health health protection tea |
| CN109527319A (en) * | 2018-12-19 | 2019-03-29 | 九道通(北京)企业管理有限公司 | Lycium ruthenicum Instant Drinks solid beverage with oxidation and removing free radicals |
| CN115634258A (en) * | 2022-09-08 | 2023-01-24 | 长春中医药大学 | Chinese medicinal compound preparation for lowering blood pressure and its preparation method |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200607518A (en) * | 2004-08-18 | 2006-03-01 | Yuan-Hung Jang | Swirled iron-core generator hub |
| CN102423407A (en) * | 2011-12-09 | 2012-04-25 | 兰州古驰生物科技有限公司 | Traditional Chinese medicine composition for conditioning sub-health state |
| CN105124347A (en) * | 2015-07-24 | 2015-12-09 | 海南木辣达生物科技有限公司 | Moringa oleifera blood-glucose-reducing composition and preparation method thereof |
| CN105230860A (en) * | 2015-06-19 | 2016-01-13 | 杨初 | Blending and making method of horseradish tree formula bag-brewing type medicinal tea |
| CN106106925A (en) * | 2016-06-28 | 2016-11-16 | 禹州市鼎信中药科技有限公司 | A kind of Radix Ginseng agate click alternative tea formula and production technology thereof |
| CN106234712A (en) * | 2016-09-05 | 2016-12-21 | 广东分子态生物股份有限公司 | A kind of freely assorted instant alternative tea and preparation method thereof |
-
2017
- 2017-05-12 CN CN201710334173.0A patent/CN107259003B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200607518A (en) * | 2004-08-18 | 2006-03-01 | Yuan-Hung Jang | Swirled iron-core generator hub |
| CN102423407A (en) * | 2011-12-09 | 2012-04-25 | 兰州古驰生物科技有限公司 | Traditional Chinese medicine composition for conditioning sub-health state |
| CN105230860A (en) * | 2015-06-19 | 2016-01-13 | 杨初 | Blending and making method of horseradish tree formula bag-brewing type medicinal tea |
| CN105124347A (en) * | 2015-07-24 | 2015-12-09 | 海南木辣达生物科技有限公司 | Moringa oleifera blood-glucose-reducing composition and preparation method thereof |
| CN106106925A (en) * | 2016-06-28 | 2016-11-16 | 禹州市鼎信中药科技有限公司 | A kind of Radix Ginseng agate click alternative tea formula and production technology thereof |
| CN106234712A (en) * | 2016-09-05 | 2016-12-21 | 广东分子态生物股份有限公司 | A kind of freely assorted instant alternative tea and preparation method thereof |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107691720A (en) * | 2017-11-08 | 2018-02-16 | 王中菊 | A kind of Moringa nurses one's health health protection tea |
| CN109527319A (en) * | 2018-12-19 | 2019-03-29 | 九道通(北京)企业管理有限公司 | Lycium ruthenicum Instant Drinks solid beverage with oxidation and removing free radicals |
| CN115634258A (en) * | 2022-09-08 | 2023-01-24 | 长春中医药大学 | Chinese medicinal compound preparation for lowering blood pressure and its preparation method |
| CN115634258B (en) * | 2022-09-08 | 2023-09-19 | 长春中医药大学 | A traditional Chinese medicine compound preparation that can lower blood pressure and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107259003B (en) | 2018-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107259571A (en) | One kind is for canteen thing and preparation method thereof | |
| CN103445262B (en) | A kind of Multifunctional meal-replacement beverage and preparation method thereof | |
| CN101664175A (en) | Natural five-color coarse cereal-melon-vegetable tea porridge and method for making same | |
| CN102578648A (en) | Fruit juice beverage | |
| CN103653144B (en) | Healthcare drink capable of improving immunity and preparation method thereof | |
| CN102987477B (en) | Health drink | |
| CN105394528A (en) | Rheumatism-relieving instant porridge electuary | |
| CN102408974A (en) | A kind of preparation method of black rice wine containing soybean isoflavone | |
| CN107259003B (en) | A kind of lycium ruthenicum Moringa ginseng health protection tea and its application | |
| CN103828983A (en) | Health-care eucommia bark tea | |
| CN105249065B (en) | A kind of grape apple composite beverage for improving immunity | |
| CN102100274A (en) | Chrysanthemum fragrance sweet potato leaf tea | |
| CN106538908A (en) | A kind of grape drink for improving the health care of sleep and manufacture method | |
| CN109937795B (en) | Method for cultivating cordyceps sinensis mycelia by taking jasmine as matrix | |
| CN107019208A (en) | A kind of Chinese medicine ferment and preparation method thereof | |
| CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
| CN104886696A (en) | Ganoderma lucidum fetus protecting fruit vinegar drink | |
| CN101828740A (en) | Rhodiola rosea chrysanthemum root beverage with beautifying function | |
| CN104450470A (en) | Cudrania tricuspidata fruit health care wine and preparation method thereof | |
| CN108077485A (en) | A kind of blue or green money willow herbal tea and preparation method thereof | |
| CN108208267A (en) | A kind of lowering blood pressure and blood fat, hypoglycemic and the moulding effect of weight-reducing bag bubble ferment health preserving tea | |
| CN107125521A (en) | A kind of fermenting plant beverage for improving sleep and preparation method thereof | |
| CN108159191B (en) | Composition for tonifying yang and invigorating kidney, application and oral liquid and preparation method thereof | |
| CN108967774A (en) | A kind of nectar and preparation method thereof | |
| KR102676880B1 (en) | Method for manufacturing herbal medicines for improving sleep disorders and herbal medicines manufactured thereby |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: 236000 Fuyang Economic Development Zone in Anhui Province, south of eight road, Guozhen power plant on the west side of four road. Patentee after: ANHUI AIHUATE BIOTECHNOLOGY CO.,LTD. Address before: 236113 Yingzhou District, Fuyang, Anhui, Fuyang Hefei modern industrial park, Hefei Avenue, No. 16, B-7 Patentee before: ANHUI AIHUATE BIOTECHNOLOGY CO.,LTD. |
|
| CP02 | Change in the address of a patent holder | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180420 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |